Literature DB >> 35175358

Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury.

Heena Khan1, Kunal Sharma1, Amit Kumar1, Amarjot Kaur1, Thakur Gurjeet Singh2.   

Abstract

INTRODUCTION: Ischemia-reperfusion injury (IRI) is the inexplicable aggravation of cellular dysfunction that results in blood flow restoration to previously ischemic tissues. COX mediates the oxidative conversion of AA to various prostaglandins and thromboxanes, which are involved in various physiological and pathological processes. In the pathophysiology of I/R injuries, COX has been found to play an important role. I/R injuries affect most vital organs and are characterized by inflammation, oxidative stress, cell death, and apoptosis, leading to morbidity and mortality.
MATERIALS AND METHODS: A systematic literature review of Bentham, Scopus, PubMed, Medline, and EMBASE (Elsevier) databases was carried out to understand the Nature and mechanistic interventions of the Cyclooxygenase modulations in ischemic injury. Here, we have discussed the COX Physiology and downstream signalling pathways modulated by COX, e.g., Camp Pathway, Peroxisome Proliferator-Activated Receptor Activity, NF-kB Signalling, PI3K/Akt Signalling in ischemic injury.
CONCLUSION: This review will discuss the various COX types, specifically COX-1 and COX-2, which are involved in developing I/R injury in organs such as the brain, spinal cord, heart, kidney, liver, and intestine.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Apoptosis; Cyclooxygenase; Excitotoxicity; Inflammation; Ischemia–reperfusion injury; Oxidative stress

Mesh:

Substances:

Year:  2022        PMID: 35175358     DOI: 10.1007/s00011-022-01546-6

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  69 in total

Review 1.  Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.

Authors:  John W Phillis; Lloyd A Horrocks; Akhlaq A Farooqui
Journal:  Brain Res Rev       Date:  2006-05-02

2.  Androgen control of cyclooxygenase expression in the rat epididymis.

Authors:  B L Cheuk; P S Leung; A C Lo; P Y Wong
Journal:  Biol Reprod       Date:  2000-09       Impact factor: 4.285

Review 3.  Pharmacological postconditioning: a molecular aspect in ischemic injury.

Authors:  Heena Khan; Ankita Kashyap; Amarjot Kaur; Thakur Gurjeet Singh
Journal:  J Pharm Pharmacol       Date:  2020-07-28       Impact factor: 3.765

4.  Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors.

Authors:  B L Fiebich; K Biber; K Lieb; D van Calker; M Berger; J Bauer; P J Gebicke-Haerter
Journal:  Glia       Date:  1996-10       Impact factor: 7.452

Review 5.  Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis.

Authors:  Shubham Vishwakarma; Shareen Singh; Thakur Gurjeet Singh
Journal:  Mol Biol Rep       Date:  2021-11-09       Impact factor: 2.316

6.  Inhibiting the PGE2 Receptor EP2 Mitigates Excitotoxicity and Ischemic Injury.

Authors:  Lexiao Li; Ying Yu; Ruida Hou; Jiukuan Hao; Jianxiong Jiang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-25

Review 7.  Reviving mitochondrial bioenergetics: A relevant approach in epilepsy.

Authors:  Shareen Singh; Thakur Gurjeet Singh; Ashish Kumar Rehni; Vivek Sharma; Manjinder Singh; Rupinder Kaur
Journal:  Mitochondrion       Date:  2021-03-26       Impact factor: 4.160

Review 8.  The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke.

Authors:  Hanna Pawluk; Alina Woźniak; Grzegorz Grześk; Renata Kołodziejska; Mariusz Kozakiewicz; Ewa Kopkowska; Elżbieta Grzechowiak; Grzegorz Kozera
Journal:  Clin Interv Aging       Date:  2020-03-23       Impact factor: 4.458

9.  Regulation of PGE2 Pathway During Cerebral Ischemia Reperfusion Injury in Rat.

Authors:  Yunfei Xu; Ying Liu; Kexin Li; Shuying Miao; Caihong Lv; Chunjiang Wang; Jie Zhao
Journal:  Cell Mol Neurobiol       Date:  2020-07-03       Impact factor: 5.046

Review 10.  EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.

Authors:  Madison N Sluter; Ruida Hou; Lexiao Li; Nelufar Yasmen; Ying Yu; Jiawang Liu; Jianxiong Jiang
Journal:  J Med Chem       Date:  2021-08-05       Impact factor: 8.039

View more
  4 in total

Review 1.  Adenosine as a Key Mediator of Neuronal Survival in Cerebral Ischemic Injury.

Authors:  Heena Khan; Parneet Kaur; Thakur Gurejet Singh; Amarjot Kaur Grewal; Shreya Sood
Journal:  Neurochem Res       Date:  2022-08-30       Impact factor: 4.414

Review 2.  Pharmacological modulation of phosphodiesterase-7 as a novel strategy for neurodegenerative disorders.

Authors:  Heena Khan; Chanchal Tiwari; Amarjot Kaur Grewal; Thakur Gurjeet Singh; Simran Chauhan; Gaber El-Saber Batiha
Journal:  Inflammopharmacology       Date:  2022-10-22       Impact factor: 5.093

Review 3.  The Molecular Mechanisms of Ferroptosis and Its Role in Blood-Brain Barrier Dysfunction.

Authors:  Xiaoshu Chen; Xinru Pang; Abrey J Yeo; Siwen Xie; Mengting Xiang; Bin Shi; Gongchang Yu; Chao Li
Journal:  Front Cell Neurosci       Date:  2022-05-19       Impact factor: 6.147

4.  DJ-1 Alleviates Neuroinflammation and the Related Blood-Spinal Cord Barrier Destruction by Suppressing NLRP3 Inflammasome Activation via SOCS1/Rac1/ROS Pathway in a Rat Model of Traumatic Spinal Cord Injury.

Authors:  Lingxin Cai; Liansheng Gao; Guoqiang Zhang; Hanhai Zeng; Xinyan Wu; Xiaoxiao Tan; Cong Qian; Gao Chen
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.